Podcasts about Medtronic

In this week's Digital Health Roundup, MedTech Insight's Marion Webb discusses her interview with Johns Hopkins researcher Axel Krieger who published study findings on autonomous surgery. Brian Bossetta highlights new FDA cybersecurity guidance and Medtronic's partnership with IRCAD to train surgeons on robots. Shubham Singh highlights his interviews with OpenWater on stroke and EnsoData on sleep. Natasha Barrow discusses FDA approval challenges with Flow Neuroscience's CEO. Tags: robotics, robotic surgery, FDA, cybersecurity, cardiology, neurology, leadership interviews, neurostimulation, commercial, medtech.

Jessica Richter is a medtech executive and a board member with MedtechWOMEN. Jessica shares her inspiring journey from B2B sales to becoming a leader in the medtech industry, including overseeing a wide range of vital functions such as clinical trial strategy, regulatory affairs, and market access. Jessica provides insightful advice on overcoming common industry challenges, and underscores the value of quality systems, expert team-building, and fostering a supportive network for women through MedtechWOMEN.   Guest links: https://www.linkedin.com/in/jessica-richter-5aa43517/ | https://medtechwomen.org/ Charity supported: Save the Children Interested in being a guest on the show or have feedback to share? Email us at theleadingdifference@velentium.com.  PRODUCTION CREDITS Host: Lindsey Dinneen Editing: Marketing Wise Producer: Velentium   EPISODE TRANSCRIPT Episode 059 - Jessica Richter  [00:00:00] Lindsey Dinneen: Hi, I'm Lindsey and I'm talking with MedTech industry leaders on how they change lives for a better world. [00:00:09] Diane Bouis: The inventions and technologies are fascinating and so are the people who work with them. [00:00:15] Frank Jaskulke: There was a period of time where I realized, fundamentally, my job was to go hang out with really smart people that are saving lives and then do work that would help them save more lives. [00:00:28] Diane Bouis: I got into the business to save lives and it is incredibly motivating to work with people who are in that same business, saving or improving lives. [00:00:38] Duane Mancini: What better industry than where I get to wake up every day and just save people's lives. [00:00:42] Lindsey Dinneen: These are extraordinary people doing extraordinary work, and this is The Leading Difference. Hello and welcome back to another episode of The Leading Difference podcast. I'm your host, Lindsey, and today I'm excited to introduce you to my guest, Jessica Richter. Jessica is the Executive Vice President and General Manager at Veranex, a global provider of end-to-end solutions that accelerate MedTech innovation through deep expertise and integrated resources. As the leader of Veranex's contract research organization and consulting services business unit, she oversees clinical trial strategy and execution, clinical data services, regulatory affairs, quality and compliance, market access and reimbursement. She also manages operations, client engagement, business development and performance tracking. A seasoned leader in medical devices and diagnostics, Jessica has extensive experience in software as a medical device, surgical innovation, oncology, aesthetics, cardiology and gastroenterology. Her tenure at Medtronic and Becton Dickinson shaped her expertise in commercialization, sales strategy, physician education, patient advocacy, and change management. Beyond her current role, Jessica serves on the boards of medtech, women and UCLA's technology development group. She actively advises startups, accelerators, and universities, including medtech innovator UC Berkeley's Master of Translational Medicine Program, the Mayo Clinic's Executive Steering Committee for the Surgical Innovation Summit, and UCLA BioDesign.   Thank you so much for being here, Jessica. I'm so excited to speak with you. [00:02:15] Jessica Richter: Likewise, Lindsey, thank you so much for having me. [00:02:18] Lindsey Dinneen: Of course. Well, I'd love if you wouldn't mind sharing a little bit about yourself and your background and what led you to medtech. [00:02:26] Jessica Richter: Awesome. Yeah, happy to. So, I was born and raised in California. I am the youngest of three girls and my entire family is really in the healthcare delivery field. So both my grandfathers were surgeons. My mother is a nurse. Both my sisters are clinical psychologists. And so when I went to school, I had aspirations at one point to get into medicine, and then through a really challenging organic chemistry class, kind of started to realize that maybe the practice of medicine wasn't where I belonged. And so I initially graduated from Berkeley, had my sights set on potentially doing something in communications, and started off in business to business sales in the telecom industry. So as far from medtech as maybe one could think. Had some experience with software, this is when Blackberries were a thing, if you remember those. And then a friend of mine was a recruiter and reached out and said, "Hey, I, I know that you're into medical and into medicine, and that was something you were interested in. Have you ever considered a career in medical device sales?" And frankly I didn't even know that that existed. I mean, this was 20 years ago, so this was before, you know, internet and all of those things existed, obviously, but it wasn't as pervasive as it is now. And so I wasn't even aware that these jobs existed. The fact that you could be working on the delivery of care but not be a healthcare provider was an eyeopening moment. And so I got in and started actually working at a surgical company called Deval. It's part of CR Bard, which is now part of Becton Dickinson, and I cut my teeth in medical device sales. And then I went on to work in a commercial role within other companies Given Imaging, Covidian, Medtronic. I ascended to sales leadership, working with key opinion leaders, working on the patient advocacy side. And then about eight years ago, I had the opportunity through an organization that we'll talk a little bit more about, called MedtechWOMEN, that I was involved in to learn about a consultancy that was looking for a head of business development marketing. It was a small group called Experian Group. I joined them and then within nine months was promoted to Chief Operating Officer, which was a position that I absolutely loved because we were working on the pre-commercial side of things and regulatory quality systems, clinical trials. And I had always had experience in the post commercial side. So eyes open to what happens, everything leading up to commercial. And I got a masterclass from my colleagues there, learning so much about what happens again, pre-commercial. But then one of the other things that came out very quickly is I've always been someone who loves operational efficiency. And I know that's not sexy or cool, but I just like seeing something that isn't working optimally and get it working optimally is something that brings joy. So I had the opportunity to do that within Experian Group, and then really help the organization, which was already very successful, go from a very successful kind of local consultancy to a much larger, broader group with a broader footprint, more global client base. And then we were acquired by the firm that I currently work with called Veranex, and that really exploded capabilities of what was a 50% consultancy to now over a thousand people with a much broader global reach in the US, in Europe, and in India. [00:05:36] Lindsey Dinneen: Wow. That is incredible. Well, first of all, thank you for sharing your story and your background and all the amazing things that led you to where you are right now. That's incredible. So many questions, in a good way. But let's dive in a little bit about, yeah, so, so tell us a little bit more about your role right now, and what are you excited about as this consultancy continues to grow and new opportunities arise. What's on the future for you? [00:06:02] Jessica Richter: So now I lead one of three business units here at Veranex. So I lead our CRO and Consulting Services Business Unit, and that encompasses regulatory, quality, and clinical, as well as commercial strategy, market access reimbursement, things like coding, coverage, payment. So we help mid-size, early stage, and some of the largest strategic medtech companies, as well as some biopharma as well with companion diagnostics, navigate sometimes the tumultuous waters needed to bring a device from inception all the way through to commercialization. Veranex also has two other business units in preclinical as well as extensive design, development and engineering. So there's leaders in each of those capacities. And what we do on CRO and consulting services is really consultative. So we work with clients to develop strategies in all of these areas, and then we roll up our sleeves and work alongside them to make sure that those strategies are actually executable, so to help them along the way. And some of our clients have teams, so it's strategic and we're advisors. Other clients, if they're early, early, may not have extensive expertise or the ability to build out teams in that way. So we go in, or our team goes in, and really provides them that support along the entire continuum. It's interesting, just today, we have a client we've been working with for two years. They're in Switzerland, but they've been working with our US and global team. They just got news from FDA that they obtained FDA clearance. And I'll tell you, I think our team is as excited as theirs because, when you're in a company, it's all that you're living, breathing, doing. When you're consulting, you're a little bit at an arm's length. So when our clients achieve their results, and it's their work, but in concert with ours, the feeling of accomplishment really is just, it's one of those that's explosive. So we've celebrated that. We ring a bell. We'll share a lot, we'll do some marketing around it with this client. But it's really fun. That's the part that really drives not just me, but members of our team as to "How can we help more companies get more products to patients?" [00:07:58] Lindsey Dinneen: I love that. First of all, congratulations, that's exciting, and I'm thrilled for your clients and for you guys because it matters so much and what a great milestone. So that's wonderful. But yeah, so I'm curious, you've seen a lot of different sides to medtech and to the business side of things, and I'm curious what are some potential stumbling blocks that you have seen that companies, especially when they're perhaps a little bit younger or earlier on in the process, what are maybe one or two stumbling blocks that you see that you think, "You know what, hey, if we put a little bit of thought into this, we can overcome this very easily, but we need to be thinking about this from the start." [00:08:36] Jessica Richter: Okay. There's two things. One of them is gonna be a shameless plug, but I swear it's true, and that's quality. I think companies don't focus enough on quality systems 'cause it's just not the fun or sexy thing, but it's literally where we see companies struggle because they think about it too late. They do just in time. They think an EQMS is the answer, and it's not the only answer, it's a component. So quality would be the short answer. The longer answer is people. So what we see is oftentimes, people, especially in a cost constrained environment, which we are today, where fundraising is tough, people do need to be financially astute as far as what they're spending and how they're spending it. But sometimes you get more by spending a little bit more to get the right advice. So for example, if somebody is expert in engineering or expert in regulatory, excellent. Know where your expertise is not, and then supplement. So either hire a consultant or bring on an employee or have a member of your board that can advise them that way. More often than not, we see people trying to just kind of figure it out as they go, which isn't a bad strategy, but there are critical decisions and inflection points along the way. For example, if you're developing a clinical trial, thinking only about your regulatory strategy and not about your commercial goals or the claims you're going to make, you are gonna have to ultimately spend twice as much when you have to do secondary studies that you could have avoided by including that in endpoints. So there's little things like that along the way where if you don't know what you don't know, it's really difficult to see those hurdles. It's helpful to bring in people, even in an advisory capacity, to help you say, "Okay, these are the hurdles that you're gonna face." You're gonna have new hurdles that maybe that you won't know or people won't know, but it's really making sure that you surround yourself with experts in those key areas. [00:10:25] Lindsey Dinneen: Mm. That's great advice. Experts in those key areas. Well, speaking to the advisory point, I'd actually love to talk about your involvement with MedtechWOMEN, and tell us a little bit about that organization and how it serves women in this industry. [00:10:39] Jessica Richter: Absolutely. Thank you for asking. It's something that I could literally talk about for this entire podcast. So, I alluded to it earlier, but MedtechWOMEN, I got, and I say "roped in" lovingly, but I was introduced to this organization, gosh, maybe a decade ago now when I was at Covidian and then Medtronic, and a mentor of mine, Amy Belt Raimundo, was one of the founders of MedtechWOMEN. And she had mentioned to me, because there weren't a lot of female leaders within that section of my business at the time, so I was paired with her and it feels like kismet because she was this spark of like, this is what badass female leadership looks like. She knew her stuff, she was really focused on the issues. She made time and said yes anytime I had a question or wanted to meet. Our conversations were really meaningful and actionable. Sometimes we just talked as friends. It wasn't always so agenda based, but she introduced me to MedtechWOMEN and shared with me that there's this organization. It's all volunteers. It's kind of membership based and it's literally women getting together talking about the issues in our industry. And it wasn't as focused on things like work-life balance, which quite frankly is a challenge, no matter what your gender is. There are great forums for talking about work-life balance and how you prioritize your health and your mental wellbeing, and that is really, really important. But some of the events that I had gone to as far as women in leadership or women in medtech were really focused on those things and that wasn't what I wanted to talk about. I wanted to see incredible pioneers or trailblazers in our industry talking about the things that mattered in industry and sharing their perspectives. And that's exactly really the thesis of MedtechWOMEN. And so it was an organization founded over a decade ago. It started really as just an annual event, this MedtechVISION event, where we brought women together on a podium talking about the issues impacting healthcare today. It evolved. So after a couple of years and a couple of different topics, what we started to see is that there was a real thirst in the community that we had beyond just that individual or that one time a year we got together for the event. And so we developed a kind of MedtechWOMEN 2.0. We brought on an Executive Director. And we essentially launched a much, much grander vision of what MedtechWOMEN was. So it included membership. It included mentorship, so formal pairings. We created a board of directory, kind of a pathway to get to more women on boards. We also have local events, networking events, virtual events in partnership with our sister organizations like MedTech Color and Diversity by Doing. And then of course we still have our annual event. And then just this past month we actually brought on a new executive director. Her name is Yvonne Bokelman. She is a longtime industry veteran, tremendous leader in medtech, and someone who's really passionate about the organization, the mission, the vision. So we're excited to see what she will do in her role here. [00:13:38] Lindsey Dinneen: Yeah. That's incredible. Thank you so much for sharing a little bit about the organization and its history and who it is serving, and it really resonated because I agree with you that there's wonderful platforms for being able to talk about some of the. Some of the topics that tend to come up quite a bit for women, especially women leaders, and I love the fact that you are fully acknowledging that those things are great as well, but that your focus is a little bit different. And so I'm curious, what are some interesting stories or things that have happened maybe unexpectedly from this network of incredible women supporting each other, learning from each other. Can you share a little bit that? [00:14:17] Jessica Richter: Oh yeah, absolutely. And I'll tell you, many of us that have been members for a long period of time will attest to the fact that job opportunities come via this network, learning opportunities, sales and business opportunities. I mean, we network in the same way that we would in any other conference or any other meeting, but deals certainly have gotten done within and at MedtechWOMEN and MedtechVISION events. But most importantly, and one of the things that I always tout, is that MedtechWOMEN is a sisterhood that will take that call. And what I mean by that is if you have a question, if you need to phone a friend-- going back to what we were talking about earlier of that network of you don't know what you don't know, but somebody probably does-- within MedtechWOMEN, someone definitely does. And so what we encourage our members and our mentors and anyone that's a part of the organization to do is reach forward and reach back. And so when I say take that call, if someone calls-- and I just had literally three conversations in the last three weeks-- with more junior people looking for career advice or wanting to have a question about regulatory or their thinking about a decision point in their job, and what should they do? I always take that call and, you know, we're all busy. We all have things to do, but that 30 minute conversation can have a really big difference. And I know for me, likewise, when I have a question, when I'm coming up against something where it's helpful to have a thought partner, sometimes you want that outside of your own company, or outside of your boss, or outside of your team. And so the MedtechWOMEN Network is incredibly powerful and very supportive. And in my experience, and I've tried it both ways, we will always take that call. [00:15:53] Lindsey Dinneen: Oh wow. That's incredible. So, okay, so mentorship and leadership is obviously a key component of your life, something that you're passionate about. From your own experience as a woman in this industry, are there any things that come to mind that you would say, just pieces of advice-- let's say for other women who might be younger in their career and they're looking to grow, they're looking to become leaders, they're looking to become maybe thought leaders, or own their own company, things like that-- what are some things that you might suggest to them from your own experience would be helpful? [00:16:27] Jessica Richter: Oh yeah. It's, it's a great question, Lindsey, because there's a lot of things. I wish we could just mind share. First and foremost, I would tell women to go for it. I think sometimes we self-sabotage or hold ourselves back if we don't have all of the information or feel like we're a hundred percent qualified. And there's been tons of studies that demonstrate that. So first and foremost, go for it. I had this conversation with one of my mentees who was taking on a new role and I said, "It's okay that you're feeling this way or that way. Do it and do it scared." Like it's okay to not feel like you have all of the confidence, right? And it doesn't mean fake it till you make it, although there's a little bit of that too. But I would say don't let fear hold you back. So that would be the first piece of it. The other piece of it is make sure that you have, really, your own board, meaning advocates, mentors, coaches, thought partners, people that you can reach out to and rely upon. And that has to work both ways. I will tell you, I have learned as much from mentees as I have learned from mentors. And so recognizing that knowledge is shared both ways, no matter what your seniority is. For people that are junior, they have their on the pulse of things that I'm not as privy to, and sometimes I feel, feel that even more strongly. Likewise for people that have been in this industry 40, 50 years, they have institutional knowledge that I only wish that I had. And so, being at this midpoint in my career, I'm sandwiched between both and really appreciate, so I would implore people that are hoping and wanting to pursue leadership, go for it. [00:18:00] Lindsey Dinneen: Yeah. Thank you for that. I, I love that advice. I really appreciate it. So, you have had such an interesting career and going from communication and sales, and then to this new role and Chief Operating Officer, all these cool things. For your own leadership style, what would you say are maybe one or two key things that you have found to be really helpful for you as a leader in the industry in the way that you approach the people that you lead? [00:18:30] Jessica Richter: Another great question, Lindsey. So I would say, well --first maybe I'll share some lessons learned 'cause I've made a ton of mistakes. So I think one of the things that I didn't appreciate early on as a leader that I definitely appreciate now, is that we all have our own lens, our view with which we take on and see the world, and that's the view in which, you know. And so as a leader, initially, my thought was, "Well, everyone kind of sees and feels it this way with their own flavor." That is not true. Everyone has their own view and that's really shaped by their family, their background, their culture, lots of different aspects. And so I think for me, some advice as a leader would be, be humble, take the time to really seek to understand, and then, even if you are heightening your communication, multiply that times three or four and then you're probably scratching the surface, 'cause people need to hear things different ways, multiple times. And it doesn't mean you need to micromanage or drill things down, but when you're leading an organization and bringing people along on a change, especially, it is important that people understand the why, the who, the what, the how come, and that they hear that re repeatedly so that they can understand it, they can buy into it, and that you're creating an environment to make sure that their questions are addressed. So, lesson learned kind of recommendation on the leadership piece. I think the other just piece of advice is that sometimes people aspire to leadership because they think it's glamorous or there's gonna be a lot of money there, or it looks like the leader doesn't have to do that much work, they're just delegating. What I would say is leadership is not glamorous. It's often thankless. It's super hard. I work tons of hours and I love the team that I work with, and so for me the why is that. But if you are not loving that, don't do that. There's plenty of opportunities that you can contribute meaningfully as an individual contributor or a principal or a subject matter expert, and that's great too. So know that if you want to lead people and be involved on that side of leadership, I welcome it. I think it's fantastic. I think there's a lot of people that get into it with a misconception of what it will look like. And I'll tell you it's worthwhile, but it's hard. [00:20:43] Lindsey Dinneen: Yeah, absolutely. Yeah, when you were talking about that it, the glamor side of things, I just remember so vividly and I, I joke about it because I think it's funny-- but very quickly, I used to own my own dance studio and I built that from the ground up. And people would say things to me like, "Oh my goodness. What you're doing, you're living your dream. That's amazing! Oh my gosh, how cool is that?" And inside, I'm like, "Ha, yeah, I mean, I spent the first two hours as the janitor this morning, and then the next two hours as the CEO. And then, you know..." And it's funny, but it's true, you wear a lot of hats as a leader and sometimes your job is literally getting down into the nitty gritty and cleaning up, and that's fine too. So I love that. [00:21:24] Jessica Richter: My quip is always from the janitor to the GM, like, "What needs to get done? There's no task too big or too small." And ultimately, I think that what you described in yourself, and I love that, is servant leadership, right? Like for me, I've always responded well, when a leader isn't above any task and doesn't ask for something that they themselves would not be willing or aren't willing to do along with their team member. And so again, that's, that's not the definition of leadership, but in my eyes, that's a definition of leadership that really resonates with me. [00:21:55] Lindsey Dinneen: Mm-hmm. I agree. Yeah. Well, speaking of stories and those kinds of fun things too, are there any that stand out to you, perhaps along your career or with MedtechWOMEN, or anything really, that just affirm to you that, "Hey, I am in the right industry at the right time, doing what I should be doing?" [00:22:14] Jessica Richter: Oh yes. So there's a couple of different specific examples. So firstly, one of the things that has happened as of late, and I feel like-- not to get too woo or California on you-- but these synchronicities where you'll be thinking about something or remembering something, and suddenly a project and people come together around it-- and again, I think that's part of the power of the network. But there was a friend of mine that I had run into at a conference, we were talking about a specific aspect of their business that was really needing some, some development, and it turned out that after that conversation, literally not a week later, I got a call from a prospective client that was interested in working in this specific space. We were able to connect them with this person that was in need of that exact thing. And it was with software and with AI and so a partnership was forged and now they are literally about to embark in this really explosive and announcement will be forthcoming about it. But there's so many examples of little nuances and synchronicities like that, that again, happen because of staying open, staying curious, that powerful network right place, right time. But I also think it's the magic of our industry. It's really small. People sometimes fail to appreciate because you have these large organizations that are hundreds of thousands of people, but the leaders within the organization are fairly connected and tight. It's really an interconnected ecosystem. So that's just kind of one broad example. There's also other really small examples of the power, I think, of MedtechWOMEN in just how it ignites and how it brings people together, especially across senior and junior roles. So when we do our networking events, we try to do them regionally, just to try to bring different people together. And you can have like the CEO of sometimes a large organization, like Lisa Earnhardt from Abbott is a member and an active participant. She often will come to events talking to someone who's their very first year in medtech. And when you see these examples of sponsors of ours really showing up and demonstrating a commitment to giving back, and you see these people that are junior that may not even know the seniority of the leader that they're speaking to, recognizing that we're all people at the end of the day, trying to really ideally propel healthcare and help patients in their journeys to health and wellness. And so when you see examples of those sparks and those little ignites, it reinforces why we're here, what it is we're doing, and really the power of the organization. [00:24:41] Lindsey Dinneen: Yeah! Well, I think that the more times that you get to see those connection points, and those synergies or whatever we wanna call them, I think that that does impact us in a way that goes, "Yeah, the work that I do matters and it's impacting people's lives and maybe in very different ways." So some of it is, yeah, that end user and that patient, and oh my goodness, what this device can do for them and their quality of life. And sometimes it's the person behind the invention and what does that journey look like for them personally and the impact on their own family and their life. So I love hearing about those connection points. [00:25:16] Jessica Richter: Well, and that's the joy of working also with, I mean, large strategics for sure, but the startup companies, oftentimes it's a physician and engineer. The physician is seeing the unmet need because of the patients coming into their clinic. They're feeling hopeless 'cause they can't address it, but also empowered because they know what to do. So those are the really fun, kind of feel good projects, especially because there is no one better equipped than a clinician, right, to say, "Okay, here's the gap." Engineers can help to design and develop, but oftentimes that's where the teams are sort of left in the lurch to say, "Okay, what do we do from here?" And so it is incredibly powerful to enable these innovators, no matter what their backgrounds are along that journey. And it's not a quick one as you know, being on the manufacturing side. It's not something that's quick or easy. It's not something that is a high success rate. And when it works, there is no better feeling. When you commercialize a device or when you get it through the FDA, that's just the start. When it's actually used in patients and you start to hear those patient advocates and those stories, and you expand indications and are able to help more patients, that's the thing that makes it worthwhile. And when the going gets tough, 'cause it does that, those are the stories, right, that really inspire us to continue. [00:26:33] Lindsey Dinneen: Yes, absolutely. Amen to that. So, okay, so I have so many thoughts swirling around, but I do want to pivot the conversation a little bit just for fun. So imagine that you were to be offered a million dollars to teach a masterclass on anything you want. It can be within your industry, but it doesn't have to be. What would you choose to teach? [00:26:53] Jessica Richter: Oh, I love this question. I'll try to make it not about our industry 'cause it's something I've been working on a lot lately, and it's a testament to patience, which is something that I think we could all use more of, but I could definitely use more of. So we rescued a dog in Covid. She's a Doberman pit mix. Her name is Poppy and she's delightful. And she was severely neglected. So when we got her, we knew she was really shut down and that we would have to do work to bring her out of her shell. My husband and I don't have kids. We have a quiet home. I knew that we could take that on. And so while I won't say I am the expert, what I have done in the four years we've now had her, is extensively worked with her on the, what I would call the "Art of the Dog Walk." So we have learned how to really master exercise, training, and discipline as a way to show affection, 'cause for a dog that shut down like that, that's really what she needed to thrive. It was humbling and very educational for me. I've always been a huge animal lover. I used to volunteer when I had a lot more time with an animal rescue. And so I was able to parlay that and work with a trainer really on honing those skills so that Poppy could not just be social in the world, but be less shut down. So it would be so fun to share a masterclass on that 'cause I had so many reflections and learnings on patience. The art of going slow, the art of taking in the world, of just slowing that down, not being on my phone, right, being really present with her. And I sort of joke with my husband, I feel like now when I walk her-- I dunno if you've seen the movie "Avatar"-- but like we connect our avatars and we like go on into this world, and it's meditative. It's our morning practice and it's something that for me has been incredibly rewarding, and challenging, and a huge learning experience that, that I would love to share. [00:28:50] Lindsey Dinneen: Oh, that's wonderful. Oh my goodness. Yes. I am a huge dog lover, so anytime someone's telling me about their dog, it's just instant happiness. [00:28:59] Jessica Richter: Likewise. And for my, my favorite thing that it will always bring a smile to my face is the unlikely animal friends, like if you see like a squirrel a dog or a kookaburra or something, you're like, "Ahh!" [00:29:10] Lindsey Dinneen: It's so cute. It's precious. Yes. I love it. And to me it reinforces, "Hey, we can actually all get along if we try." I mean, I know it's a little different in the animal kingdom, but still, I still love that. Oh my goodness. Great. Well then, how do you wish to be remembered after you leave this world? [00:29:32] Jessica Richter: You know, legacy is something, that I think is important. It's funny, I've been working with my niece on her college essays and college admittance, and reflecting back to my views when I was 18 versus my views today in the world now. And even speaking to my mom about legacy, 'cause it's something, you know, she's approaching her eighties that she thinks more and more about. So it's conversations that we have a lot. I really would love to be remembered as an enabler, as someone who really enables those around me to be successful, to achieve more, to obtain what they want right to, to drive forward. I love being around creative people and innovators and people with really expansive imaginations, and I think my superpower is kind of capturing and enabling those things. So it would be great to be able to enable more people around me. And that's true with patients and healthcare and the clients that we support as well. You know, one of the things that has always been pointed out to me-- and again, my grandfather was a huge proponent of this-- is when things aren't going well in the world, you can focus on what's going wrong or you can look for the helpers. And so, as a surgeon, he was one of those helpers. And so I think he ingrained that in me very early on. And so I'd love to be remembered as someone who is a helpful enabler. [00:30:51] Lindsey Dinneen: Hmm. Yes. That's a beautiful legacy. I love that. [00:30:54] Jessica Richter: I am curious, Lindsey, I know this is like, you're the, you're the interviewer, but how would you like to be remembered? [00:31:02] Lindsey Dinneen: Oh, thank you for asking. First time! You know, there are so many things, so many things that I love doing for other people. But I really actually resonated with your idea of enabling. And I would say mine is very similar. And that is that I love helping people achieve their dreams. And that can look like lots of different things to lots of different people. So it's when I'm working with a company, it always started with one person's idea, right? All these big companies started off as this tiny little one person's idea that became something. And I think just helping that, those sparks, especially when maybe they're eager, but they're not quite ready. They're scared, they're nervous, they're whatever, and helping them see a clear path to achieving those dreams and goals is one of my favorite things. And whether that's just a personal, I wanna run a marathon, I don't even how to know how to get started, or whether it's, I have this great idea for a book, but I am concerned about, like, "Nobody will read it, no one will care." Well, that's not the point. Let's start somewhere. And so I think for me, it's about empowering people to live the life that they want to live and hope that they can live. That's what I would love to be remembered for. [00:32:16] Jessica Richter: Well, that's beautiful. I hope that via this and the other things that you're doing, it seems like you're already on that track. [00:32:22] Lindsey Dinneen: Well, thank you. I appreciate that. I really appreciate you asking me too. Thank you. Well, and then final question, and you've sort of perhaps alluded to this-- I'll see if it's different than your first time-- what is one thing that makes you smile every time you see or think about it? [00:32:37] Jessica Richter: Oh, well, definitely the unlikely animal pairings for sure. [00:32:41] Lindsey Dinneen: Yes. [00:32:42] Jessica Richter: Anytime with family. Family is super important to me. So anytime I can spend time with our family, that is for me, a smile doesn't go off of my face. And also kind of what you said, celebrating other people's wins. And I celebrate my own as well-- I think it's important that we do that-- but there is nothing like, it's a grin, like when someone on our team has an accomplishment, the grin is twice as big, right? Because you just, to see that reflected, that success, that attainment, that win reflected for the people that you work alongside, that brings a smile to my face every time. [00:33:20] Lindsey Dinneen: Yeah, nothing quite like it, and it's so powerful. Yeah, huh. Oh my goodness. Well, this has been an amazing conversation. I don't really want it to end, but I know we have other things we have to get to today, so I just wanna take some time to say thank you so very much for being here with me, Jessica. Thank you for sharing all about your incredible career so far and all the exciting things that are to come, and speaking to MedtechWOMEN and that incredible organization. So I'm really excited for our listeners who might not have been familiar with it to go check it out, lots of opportunity there. And gosh, I just wish you the most continued success as you work to change lives for a better world. [00:34:01] Jessica Richter: Thank you, Lindsey, for hosting and I would encourage anybody who's unfamiliar with MedtechWOMEN, if you're new to industry or if you've been here a while, there is a place for you within MedtechWOMEN. Membership is super low cost. It's $150 for standard membership a year, $75 for junior members. You can follow us on LinkedIn, but highly, highly encourage everyone to join the network. And thank you for the opportunity to share a little bit more about MedtechWOMEN today. [00:34:26] Lindsey Dinneen: Of course. We are so honored to be making a donation on your behalf as a thank you for your time today to Save the Children, which works to end the cycle of poverty by ensuring communities have the resources to provide children with a healthy, educational, and safe environment. So thank you so much for choosing that charity to support. Thank you also to our listeners for tuning in, and if you're feeling as inspired as I am right now, I'd love it if you share this episode with a colleague or two, and we'll catch you next time. [00:34:57] Jessica Richter: Thanks, Lindsey. [00:34:59] Ben Trombold: The Leading Difference is brought to you by Velentium. Velentium is a full-service CDMO with 100% in-house capability to design, develop, and manufacture medical devices from class two wearables to class three active implantable medical devices. Velentium specializes in active implantables, leads, programmers, and accessories across a wide range of indications, such as neuromodulation, deep brain stimulation, cardiac management, and diabetes management. Velentium's core competencies include electrical, firmware, and mechanical design, mobile apps, embedded cybersecurity, human factors and usability, automated test systems, systems engineering, and contract manufacturing. Velentium works with clients worldwide, from startups seeking funding to established Fortune 100 companies. Visit velentium.com to explore your next step in medical device development.

In this episode of the Diabetes Innovators Series, Scott Hebl, Vice President for Program Management at Medtronic, discusses the exciting innovations and future of the MiniMed brand following its separation from Medtronic. He highlights the importance of simplifying diabetes management through advanced technology, including artificial intelligence and user-friendly devices. Scott shares his personal journey with medical devices and his passion for improving patient care. Chapters 00:00 The Excitement of Innovation in Diabetes Care 02:05 Future Innovations and Technology in Diabetes Management 06:03 Insights from the Scientific Sessions 08:19 Personal Journey and Passion for Medical Devices Resources: Medtronic Scott Hebl LinkedIn

Scaling AI across a healthcare system takes more than just good technology—it requires effective governance, operational focus, and the right data foundation. In Part 2 of our conversation with Kiran Mysore, Chief Data & Analytics Officer at Sutter Health, he explores how Sutter is operationalizing AI across its 24 hospitals and hundreds of care sites. You'll hear: How the AI Council—a cross-functional governance body—ensures alignment, safety, and momentum What makes the “Sutter Navigator” platform a game-changer for operational visibility Why “speed of business” and “speed of foundation” must be balanced to move fast and responsibly How Sutter is applying lessons from finance and retail to transform healthcare This episode is a masterclass in AI implementation at scale—perfect for health system leaders, innovators, and data executives alike.       About Kiran Kiran is the Chief Data Analytics Officer at Sutter Health, a leading not-for-profit healthcare network in America. With over 25 years of experience, Kiran has been instrumental in driving digital transformation and leveraging data and AI to generate business value across various sectors, including healthcare, technology, and consulting.    Before joining Sutter Health in September 2023, Kiran held significant roles at prestigious organizations such as Medtronic, GE, Apple, and St. Jude Medical. His expertise includes optimizing operations, developing real-time insights, and modernizing technology infrastructures. Known for his commitment to fostering data-driven cultures and championing diversity and ethical practices in data, Kiran's leadership at Sutter Health focuses on making data and insights meaningful to improve healthcare outcomes, operational efficiency, and patient care. His work exemplifies the transformative power of technology in advancing healthcare. About Bright Spots Ventures Bright Spots Ventures is a healthcare strategy and engagement company that creates content, communities, and connections to accelerate innovation. We help healthcare leaders discover what's working, and how to scale it. By bringing together health plan, hospital, and solution leaders, we facilitate the exchange of ideas that lead to measurable impact. Through our podcast, executive councils, private events, and go-to-market strategy work, we surface and amplify the “bright spots” in healthcare, proven innovations others can learn from and replicate. At our core, we exist to create trusted relationships that make real progress possible. Visit our website at www.brightspotsinhealthcare.com.  

Marty, Eric, and Dave talk about the flood of stories from one rumor post about future Vision Pro devices and new video about editing immersive video.Product Prediction Kuo: Apple working on 7 head-mounted products, roadmap starts in 2025https://9to5mac.com/2025/06/29/apple-working-on-7-head-mounted-products/ After Vision Pro's Flop, Apple Doubles Down on Headsetshttps://www.androidheadlines.com/2025/06/after-vision-pros-flop-apple-doubles-down-on-headsets.html Samsung Headset PredictionsSamsung's Upcoming XR Headset Could Beat Apple Vision Pro With Sharper 3,800 PP| OLEDoS Displays, But A Smaller Field Of View Might Be Its Biggest Drawbackhttps://wccftech.com/samsung-headset-display-better-than-vision-pro/ Samsung's Project Moohan XR headset could be similar to Vision Pro in more ways than onehttps://www.androidauthority.com/samsung-xr-headset-project-moohan-display-suppliers-3571210/Samsung's Project Moohan to have more Pixel Density than Apple Vision Prohttps://samlover.com/2025/06/26/project-moohan-to-have-more-pixel-density/ Inside BonoInside the First Feature-Length Immersive Film for Apple Vision Pro: Bono - Stories of Surrenderhttps://www.cined.com/inside-the-first-feature-length-immersive-film-for-apple-vision-pro-bono-stories-of-surrender/ Behind the Work: How The Artery Brought Bono: Stories of Surrender to Apple Vision ProHow The-Artery Brought Bono: Stories of Surrender to Apple Vision Pro | LBBOnline Vision Pro Colonoscopy Apple Vision Pro will help get to the bottom of colonoscopy cancer detectionhttps://appleinsider.com/articles/25/06/25/apple-vision-pro-will-help-get-to-the-bottom-of-colonoscopy-cancer-detection Medtronic, Cosmo to conduct GI Genius trial on Apple Visionhttps://www.massdevice.com/medtronic-cosmo-gi-genius-apple-vision-pro-study/ Rush University to Host Colonoscopy Study Using Apple Vision Prohttps://hitconsultant.net/2025/06/25/apple-vision-pro-and-medtronics-gi-genius-to-be-used-in-live-colonoscopies/Mantel Group review for enterpriseThe Vision Pro, and how to unlock its potential: a tech consultant's perspectivehttps://mantelgroup.com.au/the-vision-pro-how-to-unlock-its-potential-a-tech-consultancy-perspective/ Spatial NPC released  We released an open source "spatially intelligent NPC" app for VisionPro!https://www.reddit.com/r/augmentedreality/comments/1lkmxlb/we_released_an_open_source_spatially_intelligent/ BlackMagic camerasFilmmaking for the Vision Pro Era: Apple and Blackmagic's Immersive Video Workflowhttps://www.cined.com/filmmaking-for-the-vision-pro-era-apple-and-blackmagics-immersive-video-workflow/ CANAL+ BRINGS MOTOGP TO VISION PRO WITH BLACKMAGIC URSA CINE IMMERSIVEhttps://www.mactech.com/2025/06/27/canal-brings-motogp-to-vision-pro-with-blackmagic-ursa-cine-immersive/Blackmagic URSA Cine IMMERSIVE Tech Explainer - Shooting Apple Immersive Video for the Vision Prohttps://www.youtube.com/watch?v=QpkIEncCOfw HTML Model element A step into the spatial web: The HTML model element in Apple Vision Prohttps://www.webkit.org/blog/17118/a-step-into-the-spatial-web-the-html-model-element-in-apple-vision-pro/ New smart glassesXiaomi Unveils China's Answer to Ray-Ban Meta Smart Glasses with a Few Killer Featureshttps://www.roadtovr.com/xiaomi-ai-glasses-meta-smart-glasses-features/ Image editors2 Cool Image Editors for Vision Prohttps://www.iphoneness.com/apple-vision-pro-apps/cool-image-editors-for-vision-pro/ APPS BezelBezel app - Show your iPhone inside Apple Vision Prohttps://www.reddit.com/r/VisionPro/comments/1agdon5/bezel_app_show_your_iphone_inside_apple_vision_pro/ Show your iPhone inside Apple Vision Prohttps://nonstrict.eu/bezel/vision/ Bezel: Spatial Phone Mirroringhttps://apps.apple.com/us/app/bezel-spatial-phone-mirroring/id6476657945 MacStockMacstockconferenceandexpo.com  50$ off with code “PODTALK50”

With Stefan Simovic, Faculty of Medical Sciences, University of Kragujevac, Kragujevac - Serbia, Jacopo Francesco Imberti, Modena Polyclinic Modena University Hospital, Modena - Italy, Haran Burri, Cardiology Department, University Hospital of Geneva - Switzerland and Michael Glikson, Jesselson Integrated Heart Center of Shaare Zedek Medical Center, Jerusalem - Israel. In this podcast, Haran Burri, Michael Glikson, Stefan Simovic and Jacopo Imberti will discuss Conduction system pacing indications. This 2025 EHRA Cardio Talk Keep the rhythm podcast series is supported by Medtronic in the form of unrestricted financial support. The discussion has not been influenced in any way by its sponsor. 

Join clinical experts Cheryl Rosenfeld, DO, FACE, FACP, FSVM, ECNU, Madhuri M. Vasudevan, MD, MPH, FACE, and Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP, to learn how the AACE Patient Journey of Diabetes Technology supports people with diabetes in navigating their treatment options with confidence. This patient-friendly resource, developed from AACE clinical guidelines and reviewed by Diabetes Sisters, a leading patient advocacy organization, provides clear and accurate information on diabetes technologies, from glucose monitors to insulin delivery devices. The experts also highlight how members of the endocrine care team are using this tool to empower people with diabetes to manage their journey. This episode is brought to you with the support of Abbott, Novo Nordisk, Medtronic, and Vertex.

I'm thrilled to share some incredible insights from our latest podcast episode featuring the one and only Scott Brown, managing partner of Velora Capital. Scott's journey is nothing short of inspiring, and I can't wait for you to dive into our conversation. Here's a sneak peek of what you can expect:

Navigating Clinical Trials for Medical Device Startups: Insights from Julio Martinez-Clark of bioaccess®In this episode of The Thoughtful Entrepreneur, host Josh Elledge sits down with Julio Martinez-Clark, Founder and CEO of bioaccess®, to explore the challenges medical device startups face in navigating early-phase clinical trials. Julio draws on his extensive experience to explain how bioaccess® is helping companies conduct trials in Latin America as a strategic alternative to the U.S., offering startups an efficient and cost-effective way to progress. The conversation dives into the intricacies of regulatory compliance, data quality, and patient recruitment, offering critical insights for innovators looking to accelerate their time to market.Overcoming the Challenges of Medical Device Clinical TrialsJulio Martinez-Clark explains the complex journey from medical device innovation to market. He highlights that medical device development is often capital-intensive and time-consuming, with startups typically relying on grants in the early stages before needing millions to fund animal studies, human trials, and regulatory submissions. One of the biggest challenges that startups face is meeting investor expectations for rapid progress and clear milestones, particularly with the ultimate goal of acquisition by large players such as Medtronic or Johnson & Johnson.The U.S. clinical trial process, while rigorous, is also costly, and the lengthy approval timelines add pressure for startups already constrained by limited resources. Julio stresses that many medical device innovators underestimate the amount of time it takes to secure funding, develop products, and get approval from the FDA. He also shares how crucial it is for companies to factor in the regulatory strategies and financial resources needed to navigate these challenges without facing setbacks.To overcome these challenges, startups should build long-term financial plans and strategies, preparing for what can be a long and resource-heavy journey. This proactive approach, combined with a solid regulatory strategy, ensures that startups remain on track and avoid costly delays.About Julio Martinez-ClarkJulio Martinez-Clark is the Founder and CEO of bioaccess®, a company dedicated to helping medical device startups navigate the early stages of clinical trials and regulatory approval. With years of experience in the medical device and healthcare innovation sectors, Julio provides strategic insights into accelerating time to market and achieving regulatory compliance for cutting-edge medical technologies.About bioaccess®bioaccess® is a leading contract research organization (CRO) focused on supporting medical device startups through early-phase clinical trials, particularly in Latin America. Offering a more affordable and faster approach to clinical trials, bioaccess® helps startups overcome high costs and lengthy timelines associated with U.S.-based trials while ensuring adherence to global regulatory standards and high data quality.Links Mentioned in This Episodebioaccess® WebsiteJulio Martinez-Clark on LinkedInKey Episode HighlightsThe Fractional Legal Team...

In this wide-ranging and direct conversation, Bill George, former Medtronic CEO and Harvard Business School professor, offers a disciplined framework for leading in conditions of persistent volatility. Drawing from decades of leadership experience and research, George emphasizes that leadership today is no longer about managing processes, it is about confronting ambiguity, enabling experimentation, and sustaining purpose across shifting conditions.   Five themes stand out: Opportunity Must Be Created, Not Awaited. George argues that emerging leaders should not wait for promotions or formal permission. Instead, they should identify unaddressed problems, volunteer to lead, and deliver results without demanding titles. Career growth, he suggests, is a function of action, not seniority. Innovation Begins at the Front Lines. Whether referencing his early decision to cancel a Medtronic pacemaker program that lacked patient benefit, or urging leaders to spend less time in conference rooms and more with customers and staff, George insists that enduring breakthroughs stem from direct observation and empathy, not from internal data analysis alone. Risk Tolerance Determines Strategic Renewal. George contrasts firms that institutionalize risk such as Medtronic's venture incubation model, with those that allow internal resistance to block change. Innovation, he asserts, must be structurally protected from corporate inertia, and leaders should be judged on the courage to champion unpopular ideas that later prove transformative. Culture Must Reward Learning Over Defensiveness. Drawing parallels between U.S., European, and Japanese innovation cultures, George critiques over-regulated, failure-averse systems that suppress experimentation. True progress, he says, requires the willingness to learn through trial, adaptation, and even initial failure. AI Is a Strategic Imperative, Not a Cost Play. Rather than using AI to drive out labor costs, George advocates for using it to rethink business models entirely, supporting frontline autonomy, enabling new services, and unlocking unmet needs. He cautions leaders against adopting a defensive posture and urges them to fund experiments that explore the true potential of the technology. Throughout, George offers a leadership mindset anchored in authenticity, courage, and customer-centric design. His advice is clear: future leaders must raise their hands, operate at the edge, and move fast before the window of relevance closes.   Get Bill's book here: https://shorturl.at/3iHRb True North, Emerging Leader Edition: Leading Authentically in Today's Workplace   Here are some free gifts for you:   Overall Approach Used in Well-Managed Strategy Studies free download: www.firmsconsulting.com/OverallApproach   McKinsey & BCG winning resume free download: www.firmsconsulting.com/resumepdf   Enjoying this episode? Get access to sample advanced training episodes here: www.firmsconsulting.com/promo  

生醫工程是近年來熱門的專業，由於生醫工程是一個較新的專業，很多人對於生醫工程的職涯和出路並不熟悉。 這一集我們特別邀請到目前在腦機介面領頭羊公司 Synchron 擔任 Principal System Engineer 的張耀銓博士和我們分享他一路以來的職涯：如何從電機/電控學士轉到生醫工程博班，從學界如何透過與業界密切合作的機構進入業界、如何進到醫療器材大廠 Medtronic 和現在的 Synchron，以及在學習和求職上遇到各種挑戰與心得。 張耀銓博士也在上一集中，和我們分享了侵入式腦機介面目前的進展和 Synchron 的獨特優勢，對腦機介面發展有興趣的朋友歡迎到上一集收聽。  

HealthLeaders' Michelle Ponte sits down with Rob St. John, senior clinical director and technical fellow for the Acute Care and Monitoring Division of Medtronic, to learn how HealthCast's portfolio can allow nurses and clinicians to deliver better care without replacing them.

Ce vendredi 13 juin 2025,Christian Bito, professeur de finance à l'ESSEC Business School, et Frédéric Rozier, gérant chez Mirabaud France, se sont penchés sur les titres Leonardo DRS et Medtronic, dans On achète ou on vend ? dans l'émission C'est Votre Argent présentée par Marc Fiorentino. C'est Votre Argent est à voir ou écouter le vendredi sur BFM Business.

Join HRS Board Member Prashanthan Sanders, MBBS, PhD, FHRS (University of Adelaide) as he discusses this exciting paper, presented at Heart Rhythm 2025. He is joined in the Heart Rhythm Tv Studio in San Diego, California by Louise Segan, MBBS, MPH (Alfred Health), and Takanori Yamaguchi, MD, PhD (Saga University). This discussion took place on-site at Heart Rhythm 2025.   https://www.hrsonline.org/education/TheLead https://www.heartrhythmjournal.com/article/S1547-5271(25)01245-7/fulltext Host Disclosure(s): P. Sanders: Honoraria/Speaking/Consulting: Boston Scientific, Abbott Medical, Research: Boston Scientific, Abbott, Medtronic, Becton Dickinson, CathRx, Pacemate, Kalyan Technologies, Ceryx Medical, Biosense Webster, Inc., Hello Alfred, Abbott Medical Membership on Advisory Committees: Pacemate, Medtronic PLC, Boston Scientific, CathRx, Abbott Medical Contributor Disclosure(s): T. Yamaguchi: Honoraria/Speaking/Consulting: Abbott Japan, Biotronik, Boston Scientific, Abbott Medical, Japan Medtronic, Inc., Daiichi Sankyo, Novartis, Japan Lifeline, Nihon Kohden, Bayer Healthcare Pharmaceuticals Japan, Boehringer Ingelheim L. Segan: Nothing to disclose.

In this episode of the Global Medical Device Podcast, Etienne Nichols and regulatory expert Mike Drues take a critical look at the FDA's Manufacturer and User Facility Device Experience (MAUDE) database. While intended to serve as a vital tool for post-market surveillance, the MAUDE database is fraught with issues—from late reporting and missing data to unclear mission alignment. Mike challenges MedTech professionals to rethink how we engage with the system, exposing how widespread underreporting and data hygiene problems not only weaken safety efforts but also increase legal risk. This eye-opening discussion reveals where the breakdowns are occurring, who's responsible, and what industry and regulators can do to fix it.Key Timestamps[02:30] What is the MAUDE database, and why does it matter?[06:10] The critical difference between reportable and non-reportable adverse events[11:20] Limitations of MAUDE: Why FDA warns against using it for rate comparisons[17:45] Underreporting, late submissions, and missing data: The disturbing stats[25:00] High-profile companies dominating late reporting violations[32:10] Legal consequences: What expert witnesses look for in MAUDE data[38:50] Is it poor systems or lack of regulatory understanding causing failures?[46:00] Recommendations for manufacturers: What responsible reporting looks like[53:20] How FDA could modernize the MAUDE database to better serve patients[1:01:30] Carrots or sticks: Creating incentives vs. penalties for compliance[1:09:00] Final thoughts: The true mission of MAUDE and how to fulfill itStandout Quotes"A report in the MAUDE database is just a historical record. It doesn't say why it happened or who's at fault—just that it happened."— Mike DruesThis quote underscores the limited utility of MAUDE reports and why interpretation requires caution."If you're not a medical device professional without your tools, then you're not really a medical device professional."— Etienne NicholsA poignant reminder that compliance and quality are human-led, not software-enabled by default.Top TakeawaysLate Reporting is Widespread and RiskyNearly 30% of MAUDE reports are filed late, with 10% submitted more than six months past due. This creates legal exposure and potential patient harm.MAUDE Is Misused—Despite FDA WarningsManufacturers commonly use MAUDE for competitive analysis or trend detection, even though the FDA explicitly warns against it.Three Companies Account for Over Half of Late ReportsLarge, well-resourced companies like Medtronic and Becton Dickinson are responsible for a disproportionate share of noncompliance.Electronic Tools Help, but Culture Matters MoreSoftware can support MDR timelines, but organizations still need internal processes and urgency to act responsibly.FDA and Industry Both Need to EvolveSuggestions include AI-driven cross-referencing, tiered reporting urgency, and incentive-based compliance recognition.ReferencesFDA MAUDE Database21 CFR 803.16 – MDR Reporting RequirementsEtienne Nichols on LinkedInMedTech 101: What Is MAUDE and Why Should You Care?Think of the MAUDE database as a public logbook of adverse events involving medical

Ann Latham is the Founder of Uncommon Clarity, a consulting firm helping professionals gain cognitive clarity. As a clarity consultant, she has worked with notable businesses, including Hitachi, Boeing, and Medtronic. Ann is also the author of The Power of Clarity, The Disconnect Principle, The Clarity Papers, and Uncommon Meetings. Her insights have appeared in The New York Times, Bloomberg, and Management Today. In this episode… The word “clarity” is used frequently in business contexts, but what does it mean? For entrepreneurs and leaders, clarity involves identifying your goals and methods for achieving them. How can you gain clarity in all aspects of your professional life? Widely recognized “Clarity Queen,” Ann Latham has discovered the common roadblocks to goal progression, including a lack of specificity and clear communication. She maintains the importance of gathering enough information to make informed decisions about the next steps. This involves identifying specific decisions and action steps and developing detailed plans to execute them. In this episode of the Lead Like a Woman Show, Andrea Heuston sits down with Ann Latham, the Founder of Uncommon Clarity, to discuss how to gain clarity in your professional life. Ann explains how to accelerate results and optimize communication in meetings, the takeaways from her TEDx talk, and insights from her books.

Prashanthan Sanders, MBBS, PhD, FHRS, University of Adelaide is joined by Jenish Shroff, MBBS, MD, Australian National University, and Pugazhendhi Vijayaraman, MD, FHRS, Geisinger Heart Institute, to discuss this first-in-human feasibility study evaluated a novel helix-based leadless pacemaker (LPCSP) designed to achieve left bundle branch area pacing (LBBAP), a capability current LPs lack. The device was temporarily implanted via the internal jugular vein into the interventricular septum in 14 patients, with successful implantation in 10. Electrical performance metrics, including pacing threshold, R-wave amplitude, and impedance, were within acceptable clinical ranges. LBBAP capture was achieved in 5 patients, with no serious device-related adverse events in 85.7% of cases. The study supports the acute safety and feasibility of LPCSP for conduction system pacing.    https://www.hrsonline.org/education/TheLead https://www.heartrhythmjournal.com/article/S1547-5271(25)02378-1/fulltext Host Disclosure(s): P. Sanders: Honoraria/Speaking/Consulting: Boston Scientific, Abbott Medical, Research: Boston Scientific, Abbott, Medtronic, Becton Dickinson, CathRx, Pacemate, Kalyan Technologies, Ceryx Medical, Biosense Webster, Inc., Hello Alfred, Abbott Medical Membership on Advisory Committees: Pacemate, Medtronic PLC, Boston Scientific, CathRx, Abbott Medical Contributor Disclosure(s): P. Vijayaraman: Honoraria/Speaking/Consulting: Biotronik, Boston Scientific, Abbott Medical, Medtronic, Inc. Research (Contracted Grants for PIs and Named Investigators only): Medtronic Fellowship Support: Medtronic J. Shroff: Nothing to disclose.

This episode covers:  Cardiology this Week: A concise summary of recent studies Coronary sinus reducer: promise in refractory angina Best strategies to reach LDL cholesterol goals in high-risk patients Snapshots Host: Susanna Price Guests: Carlos Aguiar, Rasha Al-Lamee, J. Wouter Jukema, Steffen Petersen Want to watch that episode? Go to: https://esc365.escardio.org/event/1807 Want to watch that extended interview on LDL management? Go to: https://esc365.escardio.org/event/1807?resource=interview Disclaimer ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Rasha Al-Lamee has declared to have potential conflicts of interest to report: speaker's fees for Menarini pharmaceuticals, Abbott, Philips, Medtronic, Servier, Shockwave, Elixir. Advisory board: Janssen Pharmaceuticals, Abbott, Philips, Shockwave, CathWorks, Elixir. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. J. Wouter Jukema has declared to have potential conflicts of interest to report: J. Wouter Jukema/his department has received research grants from and/or was speaker (CME accredited) meetings sponsored/supported by Abbott, Amarin, Amgen, Athera, Biotronik, Boston Scientific, Dalcor, Daiichi Sankyo, Edwards Lifesciences, GE Healthcare Johnson and Johnson, Lilly, Medtronic, Merck-Schering-Plough, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi Aventis, Shockwave Medical, the Netherlands Heart Foundation, CardioVascular Research the Netherlands (CVON), the Netherlands Heart Institute and the European Community Framework KP7 Programme. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Host: Susanna Price Guest: J. Wouter Jukema Want to watch that extended interview on LDL management? Go to: https://esc365.escardio.org/event/1807?resource=interview Want to watch the full episode? Go to: https://esc365.escardio.org/event/1807 Disclaimer ESC TV Today is supported by Bristol Myers Squibb and Novartis. This scientific content and opinions expressed in the programme have not been influenced in any way by its sponsors. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. Declarations of interests Stephan Achenbach, Nicolle Kraenkel and Susanna Price have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Pfizer, Sanofi, Servier, Takeda, Tecnimede. Davide Capodanno has declared to have potential conflicts of interest to report: Bristol Myers Squibb, Daiichi Sankyo, Sanofi Aventis, Novo Nordisk, Terumo. J. Wouter Jukema has declared to have potential conflicts of interest to report: J. Wouter Jukema/his department has received research grants from and/or was speaker (CME accredited) meetings sponsored/supported by Abbott, Amarin, Amgen, Athera, Biotronik, Boston Scientific, Dalcor, Daiichi Sankyo, Edwards Lifesciences, GE Healthcare Johnson and Johnson, Lilly, Medtronic, Merck-Schering-Plough, Novartis, Novo Nordisk, Pfizer, Roche, Sanofi Aventis,Shockwave Medical, the Netherlands Heart Foundation, CardioVascular Research the Netherlands (CVON), the Netherlands Heart Institute and the European Community Framework KP7 Programme. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.

Minnesota has the highest rate of people working remotely in the Midwest, according to the Minneapolis Federal Reserve. More than a third of workers in the state worked at home at least part time in 2023. But now, five years after the pandemic, the great experiment of remote work is shaking out. More employers are calling workers back to the office. On Monday, tens of thousands of state employees who had been working remotely are required to return to work in person at least 50 percent of the time, complying with a return-to-office order from Gov. Tim Walz. Some private companies, such as 3M and Medtronic, also are dialing back their work-from-home policies and President Donald Trump has sought to end remote work for federal workers.MPR News host Angela Davis discusses what we've learned about remote work — when it works and when it doesn't — and what its future might be. Guests: Chris Farrell is a senior economics contributor for MPR News and Marketplace.  Colleen Flaherty Manchester is a professor and faculty director of the Center for Human Resources and Labor Studies in the Carlson School of Management at the University of Minnesota. She studies flexible work and other benefits and programs offered by employers. Subscribe to the MPR News with Angela Davis podcast on: Apple Podcasts, Spotify or RSS.   Use the audio player above to listen to the full conversation.     

Scott Korzenowski, sitting in for Chad today, mixes in a bunch of Timberwolves and NBA discussion throughout the hour, including a visit with Jon Krawczynski of The Athletic, with a discussion about working from home and a change in hybrid work policy at Medtronic.

Scott Korzenowski speaks about his experience working remotely since the pandemic as Medtronic asks their hybrid workers to return to the office four days each week instead of three.

#293: Today I'm sitting down for a casual solo episode spilling the tea on how things are going post-rebrand, and sharing my favorite new hack for getting things done when I feel like crashing out.Resources:Follow Marina Girgis on IG to learn more about her retreatsEpisode 225: How Reading Fiction Makes Us Raise Our Standards and Practice Self-Care with Kennedy RyanEpisode 271: How to Rebrand Your Life in 2025Episode 281: Gabrielle Union on Moving Through Creative Blocks, Embracing Vulnerability and No Longer Going 50/50Episode 283: The Business of Rebranding and Owning Your Success with WeezyEpisode 289: Choosing Alignment Over Ambition with Daria BurkeCan't Get Enough by Kennedy RyanOf My Own Making: A Memoir by Daria BurkeSubscribe to my Substack, Balance with LesSponsors:Simply Pop is a new fruit-forward bevy of prebiotic sodas with 6 grams of fiber. Go to cokeurl.com/simplyPOP to find out where you can try it.Nuuly Subscription Clothing Rental is a must-have for switching up your style. Visit nuuly.com and use the code BALANCEDLES to get $28 off your first month.Medtronic is spreading awareness about the importance of talking about women's heart health. Visit alettertomymother.com to learn more.IM8's Daily Ultimate Essentials is my go-to drink for getting all the nutrients I need. Go to IM8health.com/lucky and use code LUCKY for a free welcome kit, five free travel packs, and 10% off your order.Keep in touch:Follow on IG: @shessoluckypod @lesalfredFollow on TikTok: @shessoluckypod @lesalfredVisit our website at balancedblackgirl.comPlease note that this episode may contain paid endorsements and advertisements for products and services. Individuals on the show may have a direct or indirect financial interest in products or services referred to in this episode.Produced by Dear Media.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A conversation with a Medtronic engineer who's been with the company since the beginning of the Artificial Pancreas project. Lou Lintereur is now Chief Engineer for AID systems at Medtronic.. we talk about the recently approved Simplera Sync Sensor, changes coming to Medtronic pumps, he answers your questions about AI use, patch pumps, and the idea of a pump that needs zero user interaction. Note: this episode was recorded before Medtronic's announcement that they will spin off the Diabetes division. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Join us at an upcoming Moms' Night Out event! Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.

Send us a textJoin our host, Dr. Byron Stephens, as he speaks with Dr. Michael Kelly and Dr. Steven Glassman, two of the authors of Scoliosis Research Society–funded research recently published in the Journal of American Medical Association -- Surgery. Congratulations to all the authors on this outstanding achievement!The study, Long-Term Outcomes of Operative Versus Nonoperative Treatment for Adult Symptomatic Lumbar Scoliosis (ASLS): Durability of Treatment Effects and Impact of Related Serious Adverse Events Through 8-Year Follow-Up, was published in the Journal on April 2, 2025.To bring the study to its full 8-year follow up allowing for the JAMA publication, funding was provided by the SRS and several of the SRS industry partners and the International Spine Study Group . The SRS community and the study investigators appreciate the additional investments provided above and beyond their support of SRS, made by Globus Medical, K2M/Stryker Spine, Medtronic, NuVasive, and Zimmer Biomet.*The Scoliosis Research Society (SRS) podcast is aimed at delivering the most current and trusted information to clinicians that care for patients with scoliosis and other spinal conditions. From news in the world of spinal conditions, to discussions with thought leaders in the field, we aim to provide up-to-date, quality information that will impact the daily practice of spinal conditions.

S&P Futures are trading lower this morning. There are news reports indicating that Isreal is preparing to launch a strike on Iran. In March, President Trump gave Iran a 60-day deadline to reach a deal, that deadline has passed. House Republicans appear close to passing their reconciliation bill, The Senate will likely make changes to the bill. If the bill passes in the House and Senate, it will likely be a negative for markets as it will increase the deficit. Yesterday, President Trump unveiled a missile defense plan, LHX shares are higher. Medtronic plans to separate its diabetes business into a stand-alone company. Take Two announced a $1 Billion stock offering. KEYS, BIDU, & LOW are higher after earning announcements. After the bell today SNOW, ZM and URBN are set to report. On Thursday morning ADI, BJ & RL will repor

US House Speaker Johnson said a Thursday tax bill floor vote is still realistic.China's Commerce Ministry said US measures on China's advanced chips are typical of unilateral bullying and protectionism.Europe opened mostly lower but now trade mixed, US equity futures are in the red.USD remains out of love, GBP digests hot CPI data, EUR/USD back above 1.13.Bearish bias in play, Gilts lag after hot CPI, USTs await fiscal updates.Energy and gold boosted by reports Israel is preparing a possible strike on Iranian nuclear facilities.Looking ahead, G7 Central Bank and Finance Ministers Meeting, Speakers including ECB's Lagarde, Lane, Nagel & Cipollone, Fed's Barkin & Bowman, Supply from the US, Earnings from Snowflake, Zoom, Target, TJX, VF Corp & Medtronic.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

Celso Otero, gestor de Renta 4 Gestora, repasa la cotización de Target, Lowes, Medtronic y Palo Alto

Die Reaktion auf die meisten Quartalszahlen fallen vor dem Opening der Wall Street negativ aus. Neben Palo Alto Networks, stehen die Aktien von Target, TJX, der VF Corp. und Medtronic teils stärker unter Druck. Die Aktien des Baumarkt-Riesen Lowe's tendieren nach den Ergebnissen hingegen freundlich. Der Dow Jones wird vor allem durch die Aktien von UnitedHealth belastet. Neben einer Abstufung durch die HSBC, mit einem Kursziel von nur noch $270 Dollar, berichtet The Guardian über den zunehmenden Verdacht von Betrug. Dass die Inflation in Großbritannien die Ziele übertroffen hat, treibt außerdem auch die Renditen der US-Staatsanleihen leicht nach oben. CNN berichtet zudem, dass laut Informationen des US-Geheimdienstes, Israel einen Angriff auf Irans Atomanlagen in Erwägung zieht. Ein Podcast - featured by Handelsblatt. +++Erhalte einen exklusiven 15% Rabatt auf Saily eSIM Datentarife! Lade die Saily-App herunter und benutze den Code wallstreet beim Bezahlen: https://saily.com/wallstreet +++ +++EXKLUSIVER NordVPN Deal ➼ https://nordvpn.com/Wallstreet Jetzt risikofrei testen mit einer 30-Tage-Geld-zurück-Garantie!+++ +++ Alle Rabattcodes und Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/wallstreet_podcast +++ Der Podcast wird vermarktet durch die Ad Alliance. Die allgemeinen Datenschutzrichtlinien der Ad Alliance finden Sie unter https://datenschutz.ad-alliance.de/podcast.html Die Ad Alliance verarbeitet im Zusammenhang mit dem Angebot die Podcasts-Daten. Wenn Sie der automatischen Übermittlung der Daten widersprechen wollen, klicken Sie hier: https://datenschutz.ad-alliance.de/podcast.html

Die Reaktion auf die meisten Quartalszahlen fallen vor dem Opening der Wall Street negativ aus. Neben Palo Alto Networks, stehen die Aktien von Target, TJX, der VF Corp. und Medtronic teils stärker unter Druck. Die Aktien des Baumarkt-Riesen Lowe's tendieren nach den Ergebnissen hingegen freundlich. Der Dow Jones wird vor allem durch die Aktien von UnitedHealth belastet. Neben einer Abstufung durch die HSBC, mit einem Kursziel von nur noch $270 Dollar, berichtet The Guardian über den zunehmenden Verdacht von Betrug. Dass die Inflation in Großbritannien die Ziele übertroffen hat, treibt außerdem auch die Renditen der US-Staatsanleihen leicht nach oben. CNN berichtet zudem, dass laut Informationen des US-Geheimdienstes, Israel einen Angriff auf Irans Atomanlagen in Erwägung zieht. Abonniere den Podcast, um keine Folge zu verpassen! ____ Folge uns, um auf dem Laufenden zu bleiben: • X: http://fal.cn/SQtwitter • LinkedIn: http://fal.cn/SQlinkedin • Instagram: http://fal.cn/SQInstagram

Today, we're excited to feature Michelle Davey, CEO of Wheel. Wheel is redefining virtual care by connecting clinicians to telehealth opportunities and equipping healthcare organizations with scalable, tech-enabled solutions. Under Michelle's leadership, the company has become a leading platform expanding access to care nationwide. Before Wheel, Michelle brought together experience from Google, Favor Delivery, and Medtronic—insight that now helps shape her vision for the future of care delivery.In this episode, we dive into how Wheel is powering virtual care infrastructure for enterprise healthcare, the strategic thinking behind acquiring GoodRx's virtual care platform, how Michelle sees the future of telehealth evolving across consumer and pharma markets, and what founders should consider when navigating M&A in digital health.

In this episode, I sit down with Shay Domangue, PA-C, whose career path took a bold and inspiring turn — from hospitalist PA/ internal medicine to building her own social media business in elder care to transitioning to marketing development in the pharmaceutical device industry. She's now the Gulf Coast Field Market Development Specialist in the Renal Denervation business unit for Medtronic and is also raising two little humans (with her husband's help).Shay shares what it was like to reach a breaking point in clinical medicine and how listening to that inner voice led her to explore something new. She didn't just walk away — she walked toward a more aligned, values-based life and career.We talk about the early days of entrepreneurship, the emotional and logistical challenges of building something from scratch, and the surprising role that networking played in her transition into the pharmaceutical industry.Shay opens up about redefining success, protecting her energy, and how work-life balance has become a non-negotiable in her new chapter. She also drops some hard-earned wisdom for clinicians who are feeling stuck or wondering what else is out there — especially if you've ever thought, “I can't do this for 20 more years.”This conversation is for you if you're craving purpose, dreaming of flexibility, or just want to hear from someone who's made a major pivot and lived to tell the tale.CONNECT WITH SHAY:Linkedin.com/in/shaydomangueShay's polypharmacy info on TikTok: @elder.care.hubHOPE'S BOOK:⁠⁠Healing Clinician Burnout, How to Revive Your Life and Career ⁠⁠(available in ebook and paperback)CONNECT AND SIGN UP FOR COACHING:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's Website: www.coachhopecook.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's IG @coachhopecook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's FB @hopeallencook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's LinkedIn: hope-cook-56041283/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Hope's YouTube @coachhopecook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Email: hope.cook@gmail.comLove y'all, and remember: There's always hope!

In episode 2 of Launch Point, Jeremy is joined by Orlando Gafford, an expert in Organizational Change Management who's helped companies like Medtronic, Cargill and Grainger successfully navigate transformation. Jeremy and Orlando discuss how to lead through change, empower teams and build lasting adoption -- especially during technology and process shifts.

Medtronic, Inc, etc. v. CIR

Want To Learn How To Grow Your Territory?? If so → https://www.newtomedicaldevicesales.com/podcastFrom filing for bankruptcy to working with the top medical device companies, Roxy Tirado shares her full journey. Topics include grit and perseverance, what it's really like being a female in medical device sales, landing multiple job offers in six weeks, surviving and thriving at Medtronic and Intuitive, the pressure of big-name companies, building confidence, preparing like a pro, investing in mentorship, and staying grounded in gratitude and humility.Key Takeaways:Don't wait for rock bottom. If you're feeling stuck or beat down in your current role, don't wait for a breaking point—make the move now.You don't need sales experience. Roxy broke into top companies like Medtronic with zero B2B sales experience. Hard work and coachability mattered more.Ask for help. Utilize mentors and community. Roxy leaned on others when she doubted herself, and it made all the difference.Be human first, sales rep second. Build relationships with honesty and authenticity. People buy from reps they trust, not robots with brochures.Play the long game. It's not about a quick sale—it's about becoming someone your clients can count on for the long haul.00:00:00 - Start00:02:04 - Who Is Roxy Tirado00:08:00 - What Was Your Experience, First 6 Months With Medtronic00:16:11 - Finding Motivation While Being Told You Will Fail Every Day00:21:09 - Accepting Failure To Succeed00:26:44 - Keep Relationships When You Move On00:39:13 - Changing Companies00:46:09 - Reflecting On From Being Bankrupt To Successful00:55:58 - Biggest Takeaways From The Last 3 Years In My Career01:04:15 - Future Plans

Do you want to get into Medical Device Sales?? If so →  https://www.newtomedicaldevicesales.com/podcastFrom filing for bankruptcy to working with the top medical device companies, Roxy Tirado shares her full journey. Topics include grit and perseverance, what it's really like being a female in medical device sales, landing multiple job offers in six weeks, surviving and thriving at Medtronic and Intuitive, the pressure of big-name companies, building confidence, preparing like a pro, investing in mentorship, and staying grounded in gratitude and humility.Key Takeaways:Don't wait for rock bottom.If you're feeling stuck or beat down in your current role, don't wait for a breaking point—make the move now.You don't need sales experience.Roxy broke into top companies like Medtronic with zero B2B sales experience. Hard work and coachability mattered more.Ask for help.Utilize mentors and community. Roxy leaned on others when she doubted herself, and it made all the difference.Be human first, sales rep second.Build relationships with honesty and authenticity. People buy from reps they trust, not robots with brochures.Play the long game.It's not about a quick sale—it's about becoming someone your clients can count on for the long haul.00:00:00 - Start00:02:04 - Who Is Roxy Tirado00:08:01 - What Was Your Experience, First 6 Months With Medtronic00:16:11 - Finding Motivation While Being Told You Will Fail Every Day00:21:09 - Accepting Failure To Succeed00:26:44 - Keep Relationships When You Move On00:39:13 - Changing Companies00:46:09 - Reflecting On From Being Bankrupt To Successful00:55:58 - Biggest Takeaways From The Last 3 Years In My Career01:04:15 - Future Plans

With us today is award winning television personality Star Jones, who is a longtime Women's Heart Health Advocate. She is here to discuss her journey as a survivor of heart disease and the launch of Medtronic's Letter to My Mother Campaign, which encourages women to take the pledge to talk to their mother or the women in their life about heart health.   Heart disease has been the leading cause of death among women in the U.S. for more than a century and impacts more than 60 million women today. For women of color, these rates are even higher, with 59% of Black women and 43% of Hispanic women experiencing some kind of heart disease.    One-third of women (30%) have not talked with a healthcare provider about their heart health and 56% of women report having never discussed heart health with their mother or other women in their family.   Head over to  ALetterToMyMother.com  and get involved. You could be saving a life. #hearthealth #cardiovascularhealth #womenshealth #womenshearthealth #africanamericanwomen #blackwomen #hispanicwomen #healtlh #medicine #mothersday 

With us today is award winning television personality Star Jones, who is a longtime Women's Heart Health Advocate. She is here to discuss her journey as a survivor of heart disease and the launch of Medtronic's Letter to My Mother Campaign, which encourages women to take the pledge to talk to their mother or the women in their life about heart health.   Heart disease has been the leading cause of death among women in the U.S. for more than a century and impacts more than 60 million women today. For women of color, these rates are even higher, with 59% of Black women and 43% of Hispanic women experiencing some kind of heart disease.    One-third of women (30%) have not talked with a healthcare provider about their heart health and 56% of women report having never discussed heart health with their mother or other women in their family.   Head over to  ALetterToMyMother.com  and get involved. You could be saving a life. #hearthealth #cardiovascularhealth #womenshealth #womenshearthealth #africanamericanwomen #blackwomen #hispanicwomen #healtlh #medicine #mothersday 

Terresa Zimmerman is an entrepreneur, author, advisor, and mentor to business owners. Terresa traveled the world for decades working on business and brand strategy challenges with the world's largest organizations, cross-industry, rooted in B2B, including Fiserv, QUALCOMM, NVIDIA, Brocade, Gerdau, Teck, Medtronic, and more. We can only guess how that led her to become the only female founder of a men's underwear brand, Wood Underwear®. With Wood, she quickly discovered her love for Main Street and all the small businesses that fuel our communities and neighborhoods. She is a 3X award-winning author of the best-selling Oh, Lords! She is an investor and co-founder of an enterprise software company and has been recognized for her advocacy of women founders and aspiring entrepreneurs.Terresa is forever training for another big run and trying to improve her golf game. She and husband, David, live in North Carolina, with Aussies, Whizkey, and Tequila. You can find Terresa on LinkedIn.Connect with Terresa here:https://www.linkedin.com/in/terresachristensonzimmerman/www.woodunderwearwoodunderwear.com and mainstreetmatters.coClick below to download our free template for 3 high-impact posts for LinkedIn:https://www.thetimetogrow.com/ecsposttemplates

This podcast is brought to you by Outcomes Rocket, your exclusive healthcare marketing agency. Learn how to accelerate your growth by going to outcomesrocket.com As care delivery rapidly shifts beyond hospital walls, Medtronic is redefining patient monitoring and safety. In this episode, Blake Tatum, Vice President of U.S. Sales, Marketing, and Global Training for Medtronic Acute Care and Monitoring, discussed how the division supports over 115 million U.S. patients annually with technologies for blood oxygenation, airway management, and patient monitoring. As healthcare shifts toward ambulatory surgery centers (ASCs) and hospital-to-home care, Medtronic is investing in adapting its acute care solutions to these evolving settings. Their focus is on improving patient safety, reducing complications, and increasing efficiency through technologies like BIS anesthesia monitoring and McGrath video laryngoscopes. What sets Medtronic apart is its ability to integrate seamlessly with existing systems, combined with a dedicated ASC support team and access to Medtronic's broader portfolio. The ultimate goal is to deliver clinically proven, scalable solutions that enhance outcomes while meeting new care and reimbursement models. Tune in to learn how Medtronic Acute Care and Monitoring is adapting to support ambulatory surgery centers and hospital-to-home care with innovative, scalable solutions! Resources: Connect with and follow Blake Tatum on LinkedIn. Follow Medtronic on LinkedIn and explore their website. Check out the Medtronic Acute Care and Monitoring website. Check out their Portfolio Brochure here. Listen to Blake Tatum's previous episode on the Outcomes Rocket here. 

Your annual health checkup is a good start. But it's not enough.You're in your 40s. Your doctor says you're fine. Your weight looks fine.But your energy is low. Your sleep is off. Something just feels… off.Amanda Lim sees this every day.She's a Harvard-certified coach and co-founder of Singapore's first Metabolic Clinic,  advising companies like Google, PayPal, and Medtronic.Her message?You can look lean and healthy, and still be metabolically unwell.In Singapore, many people look slim and fit, yet we're facing a diabetes crisis.Most annual checkups don't catch it. They miss key signs like:Skeletal muscle mass (SMI)Visceral fatFasting insulinVO₂ maxIn this episode of How to Live, Amanda and I unpack the real health reset for your 40s — metabolism, muscle, and how to build strength from the inside out.Episode Shownoteshttps://howtolive.life/episode/093-muscle-metabolisim-midlife-reset-with-amanda-limConnect with Amandahttps://www.liftclinic.org/How to Live NewsletterGo deeper with articles every 2-3 weeks. No spam. https://sharadlal.substack.com/ Leave us a messagehttps://howtolive.life/contactAbout Sharad Lalhttps://www.sharadlal.net/Follow usLinkedin: https://www.linkedin.com/in/sharadlal24/Facebook: https://www.facebook.com/PodcastHowtolive/Instagram: https://www.instagram.com/podcasthowtolive/

Colibri Heart Valve LLC v. Medtronic Corevalve, LLC

US equity futures are pointing to a higher open today. European markets are firmer, following notable strength in Asian markets. Global markets influenced by China Commerce Ministry's remark that Beijing is evaluating the US offer on trade negotiations, which signals China's openness to discussions. The softened tone now is being seen as a latest de-escalation signal following recent reports that Beijing has quietly exempted certain US-made goods from tariffs. Japan also aims to achieve a trade agreement with the US in June, though the country has suggested that treasury holdings are among cards it may use in talks.Companies mentioned: Viper Energy, GE HealthCare, Johnson & Johnson, Medtronic, JetBlue Airways

Join host Prashanthan Sanders, MBBS, PhD, FHRS, and episode guests Jason G. Andrade, MD, FHRS, and Melanie Gunawardene, MD, as they discuss Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation. This discussion was recorded in person at EHRA 2025 in Vienna, Austria. The article under discussion was presented at EHRA 2025 and simultaneously published in the New England Journal of Medicine.   https://www.hrsonline.org/education/TheLead https://www.nejm.org/doi/full/10.1056/NEJMoa2502280   Host Disclosure(s): P. Sanders: Honoraria/Speaking/Consulting: Boston Scientific, Abbott Medical Research: Boston Scientific, Abbott, Medtronic, Becton Dickinson, CathRx, Pacemate, Kalyan Technologies, Ceryx Medical, Biosense Webster, Inc., Hello Alfred, Abbott Medical; Membership on Advisory Committees: Pacemate, Medtronic PLC, Boston Scientific, CathRx, Abbott Medical   Contributor Disclosure(s): M. Gunawrdene: Honoraria/Speaking/Consulting: Farapulse, Abbott Medical, Boston Scientific, Medtronic, Biotronik, Luma Vision, Bristol Myers Squibb J. Andrade: Honoraria/Speaking/Consulting: Boston Scientific, Medtronic, Inc., Biosense Webster, Inc.

In this jam-packed episode, Dr. Jeremy Pettus and Dr. Steve Edelman team up with special guest Dr. David Ahn to break down the latest and greatest in diabetes technology for 2025. From extended-wear CGMs to fully automatic hybrid closed-loop pumps and dual-hormonal systems, this episode is your complete guide to what's available now and what's coming soon. Whether you're on MDI, using a pump, or considering a tech upgrade, this conversation will help you navigate the expanding world of devices—and find the right setup for you.Key Topics:Extended-Wear CGMs: The Dexcom G7 now lasts over 15 days—and the Eversense implantable sensor lasts a full year.Over-the-Counter CGMs: Learn about Dexcom Stelo and Abbott Lingo, designed for people without diabetes.New Pump Launches: Including Tandem Mobi, Beta Bionics iLet, Sequel Twist, and Medtronic's MiniMed™ 780G with Simplera Sync sensor.Medtronic Simplera Sync: What to know about its U.S. launch, wear time, and integration with the 780G system.Dual-Hormone Systems: Explore how glucagon is being used alongside insulin to prevent lows and simplify diabetes management.Ketone Monitoring: Continuous ketone sensors are on the horizon, and they could change how we detect and prevent DKA.Improved App Integration: Discover updates in CGM and pump interfaces for iPhone and Android, including Libre 3+ and universal app platforms.Customizing Your Combo: Why matching the right CGM with the right pump (or sticking with MDI) is more doable—and more important—than ever. ★ Support this podcast ★

  If you're feeling like your team is losing to the competition and you can't figure out why, then you are not alone! Your efforts to build a great team might not be working as expected, and instead of improved performance, you might be experiencing disengagement and frustration among your team members. It's time to turn things around and create a winning team culture that drives success. Uncover the surprising twist that takes employee engagement to the next level. You won't believe how a simple shift in perspective can transform teams from average to extraordinary. And the best part? It's a game-changer for any business, regardless of industry. Stay tuned to find out how this unexpected approach leads to exceptional team performance and leaves your competition in awe. You won't want to miss this! Build Great Teams with Collaboration Creating a culture of collaboration within teams fosters innovation and productivity. By encouraging open communication and teamwork, organizations can leverage the diverse skills and perspectives of their members. Collaborative efforts lead to enhanced problem-solving and creativity, driving the team towards success. This week's special guest is Don Yaeger Don Yaeger, a distinguished journalist and accomplished author, boasts an extensive background in sports and business. As the author of 40 books, including 12 New York Times bestsellers, Don's expertise is widely recognized. With a focus on team dynamics and leadership, his insights are particularly valuable for business leaders and managers seeking to optimize team performance and engagement. Don's in-depth research and comprehensive understanding of high-performance principles make him a respected authority in the realm of team building and organizational excellence. His wealth of experience positions him as a leading figure in providing practical strategies and actionable advice for enhancing team effectiveness and driving overall success in the business landscape. This is his story: Don Yaeger, a seasoned journalist and author, shares his journey of discovering the elements that make great teams in business. With a career spanning big newspapers and Sports Illustrated, Don's insatiable appetite for learning led him to write 40 books, with 12 becoming New York Times bestsellers. His relentless pursuit of knowledge didn't stop there; he also hosts the Corporate Competitor podcast, where he delves into the wisdom of successful individuals. Don's immersion in the world of great teams didn't happen overnight. Over a decade, he meticulously studied top-performing sports teams like Nick Saban's Alabama football team and the mid-90s Chicago Bulls, as well as outstanding businesses like Delta Airlines and Chick Fil A. This deep dive culminated in his book "Great Teams," where he identified 16 key differentiators of exceptional teams. Don's journey is a testament to the power of continuous learning and the relentless pursuit of excellence, inspiring leaders and managers to cultivate a culture of growth and engagement within their teams. Great teams are committed to things that average teams aren't. They're committed to things like creating an environment where employees believe that they're locked into each other and that they're beholden to each other, that they're better because of each other. - Don Yaeger In this episode, you will be able to: Uncover the secrets to building great teams that drive business success. Explore the crucial role of culture in achieving outstanding team performance. Implement powerful strategies to boost employee engagement and motivation. Harness the impactful leadership techniques that drive exceptional team performance. Discover invaluable insights from success stories in sports and business.   The key moments in this episode are: 00:00:00 - The Importance of Having a Sense of Purpose 00:07:36 - What Makes Great Teams Great 00:11:49 - Building a Team Others Want to Join 00:13:07 - Overcoming Complacency 00:14:28 - The Power of Coaching and Success Principles 00:16:06 - Success Leaves Clues 00:17:56 - The Role of Team Behavior 00:21:36 - Culture, Behavior, and Habits 00:27:02 - The Power of Purpose 00:29:14 - The Importance of Team Commitment 00:30:43 - Making a Difference in Business 00:34:48 - Employee Engagement and Impact 00:36:35 - What Makes Great Teams Great 00:40:26 - Don Yaeger's All-Time Favorite Movie Timestamped summary of this episode: 00:00:00 - The Importance of Having a Sense of Purpose Don Yaeger emphasizes the importance of not just knowing, but feeling the sense of purpose within a team. He discusses how the best teams believe they are part of something bigger than themselves. 00:07:36 - What Makes Great Teams Great Don Yaeger shares his insights on what makes great teams stand out, highlighting the importance of continuous learning, mentoring culture, and a strong sense of purpose as key factors in achieving greatness. 00:11:49 - Building a Team Others Want to Join Don Yaeger discusses the significance of being the team that others aspire to join. He emphasizes the importance of being the organization that people are working to figure out how to join, rather than the team losing people to competitors. 00:13:07 - Overcoming Complacency Don Yaeger addresses the issue of complacency and its impact on organizations. He discusses how human nature can lead to complacency, and the importance of staying vigilant and continuously improving, even during times of success. 00:14:28 - The Power of Coaching and Success Principles Don Yaeger shares how he coached his son's losing team and emphasized success principles to turn the team's performance around. 00:16:06 - Success Leaves Clues Don Yaeger discusses the importance of studying successful individuals and teams to learn from their experiences and apply those lessons to achieve greatness. 00:17:56 - The Role of Team Behavior Don Yaeger emphasizes the significance of team behavior, communication, and camaraderie in achieving success, rather than solely crediting coaching for a team's victory. 00:21:36 - Culture, Behavior, and Habits Don Yaeger explains how culture shapes behaviors, which in turn form habits leading to sustained excellence, highlighting the importance of intentionally designing a positive culture within organizations. 00:27:02 - The Power of Purpose Don Yaeger shares how a sense of purpose and belonging to something bigger than oneself is crucial for team success, using the example of USA Basketball's transformation under Coach Mike Krzyzewski. 00:29:14 - The Importance of Team Commitment Don Yaeger discusses the importance of basketball players respecting and honoring members of the United States armed forces, emphasizing the responsibility they have as representatives of their country. 00:30:43 - Making a Difference in Business Yaeger shares a story about Medtronic, showing how bringing in families to thank employees for their work makes them realize the impact they have on people's lives, fostering a sense of purpose in their work. 00:34:48 - Employee Engagement and Impact The conversation highlights the significance of employees believing that their work makes a difference and the impact it has on their engagement and satisfaction, ultimately leading to better outcomes for the organization. 00:36:35 - What Makes Great Teams Great Yaeger emphasizes that great teams are committed to creating an environment where employees feel connected and responsible for each other, believing that their work changes lives and treating them differently than other organizations would. 00:40:26 - Don Yaeger's All-Time Favorite Movie Yaeger shares his favorite sports movie, "Hoosiers," emphasizing the idea of coming together to achieve amazing things, reflecting the themes of teamwork and commitment discussed in the episode. Importance of Culture in Teams Culture forms the foundation of a team, shaping behaviors, attitudes, and values. A positive and inclusive culture cultivates trust and unity among team members, fostering a sense of belonging and shared purpose. Leaders play a crucial role in shaping and nurturing a culture that empowers individuals and drives collective success. Effective Employee Engagement Strategies Engaged employees are more productive, motivated, and committed to the organization's goals. Implementing strategies that recognize and value employees' contributions fosters a sense of ownership and loyalty. By soliciting feedback, offering growth opportunities, and promoting a healthy work-life balance, leaders can create a work environment where employees thrive and contribute their best work. The resources mentioned in this episode are: Connect with Don Yaeger on LinkedIn for more insights and inspiration on building great teams. Visit Don Yaeger's website at donyaeger.com to explore his work, books, and speaking engagements. Check out the Corporate Competitor Podcast at corporatecompetitorpodcast.com for valuable leadership and team-building content. Explore Leadfeeder for real-time website visitor tracking and lead engagement to revolutionize your lead generation and sales efforts. Download Fly Message for free to save time and increase productivity with a personal writing assistant and text expander.

Eoin sits down with Graham to chat about his recent trip with Medtronic to the ATTD conference in Amsterdam.ATTD stands for 'Advanced Technologies & Treatments for Diabetes' and Eoin discusses some of the things he took away from the conference including:His changing attitude towards pumps.Interesting exercises undertaken at the conference.Observations from a restaurant full of T1Ds.As always, be sure to rate, comment, subscribe and share. Your interaction and feedback really helps the podcast. The more Diabetics that we reach, the bigger impact we can make!Questions & Stories for the Podcast?:theinsuleoinpodcast@gmail.comConnect, Learn & Work with Eoin:https://linktr.ee/insuleoin Hosted on Acast. See acast.com/privacy for more information.

In this episode of Work in Progress, Dr. Sally Saba, vice president and global chief inclusion and diversity officer for Medtronic and president of Medtronic Foundation, joins me to discuss the organization's Medtronic Spark initiative, a ten-year global committment to introduce one million students from low-income households into high-paying health tech careers. Technology has transformed the health care sector for the past few decades, from robotics to wearable technology, to telemedicine, and, of course, artificial intelligence. This is creating a huge and growing talent gap in health tech, both in the U.S. and around the world. And the way you do those jobs is also changing. "They say between around 11 million of shortages just within the next four to five years. You add onto that how AI is going to transform and evolve the landscape of education faster than people can keep up," says Dr. Saba. The Medtronic Spark initiative intends to prepare one million workers for those jobs today and in the future. "They say that 65% of students in schools today will work in jobs that don't even exist yet, and 45% of the workforce today will need new reskilling to even be able to keep up with that future." Saba adds. In the podcast, she explains that initiative will focus on students through high school, right before they start looking at their careers. 'We don't want to touch lives, we want to change the trajectory of lives,' Saba says. Medtronic Spark will be a combination of online and hands-on training, with a focus on making it accessible for low-incoming families. It will include three main components: innovation labs for students to tinker with technology, scholarships to help students graduate, and job-ready credential programs in high-demand health care technology roles like clinical mapping and pacemakers. Medtronic employees will be able to get involve by sponsoring students, providing mentorship, and helping designing credentialling programs. Medtronic is in 150 countries and 40% of the initial programing will be in the U.S. Find out more details of the initiative in the podcast, which you can listen to here or wherever you get your podcasts. You can also find our podcasts on the Work in Progress YouTube channel. Episode 360: Dr. Sally Saba, VP Chief Global Inclusion and Diversity Officer, Medtronic; President, Medtronic FoundationHost & Executive Producer: Ramona Schindelheim, Editor-in-Chief, WorkingNationProducer: Larry BuhlTheme Music: Composed by Lee Rosevere and licensed under CC by 4Transcript: Download the transcript for this episode hereWork in Progress Podcast: Catch up on previous episodes here

LIVE from Transform 2025 in Las Vegas! Amira Barger is an award-winning Executive Vice President of Communications and Head of DEI Advisory at Edelman, providing senior reputation management and polycultural counsel to clients across the globe. Recently named Woman of the Year by Women Health Care Executives, Top 100 Executives by Involve People, Top CMOs of 2024 by the CMO Alliance, Top 50 Global DEI Professionals by OnConferences, Top 100 People Leaders by Mogul, Fearlessly Authentic Leader by Leaderology, and 30 under 40 in Healthcare Innovation by Business Insider – Amira is a scholar, practitioner and thought leader who brings more than 20 years of experience in strategic communications that reach stakeholders, mobilize the community and inspire action. Amira has global experience in pharma/healthcare communications, corporate branding, web and social media, M&A experience, media relations, team management, sustainability/social impact, reputation management, and DEI. Throughout her career, Amira has utilized these competency areas for clients such as: CVS Health, Eli Lilly, Walgreens, Hologic, Genentech, Pfizer, GSK/Haleon, BMS, Zoetis, Alkermes, Regeneron, Amgen, Medtronic, Children's Miracle Network, Kaiser Permanente, First 5 Los Angeles, Covered California, Centers for Disease Control and Prevention, FEMA, and California Community Colleges. Adam and Amira discuss: - How does “niceness” in workplace culture hold back real DEI progress, and what should leaders do instead? - Challenging Workplace Norms to Advance DEI and Justice - Empowering Women in Leadership - Valuing the Whole Human - "How can leaders move beyond surface-level well-being initiatives to truly create workplaces that honor employees as whole humans, not just workers? Connect with Amira: https://www.linkedin.com/in/amirabarger/ Live from Transform 2025, we're bringing you an exclusive podcast series packed with insights from some of the brightest minds in hiring, talent strategy, and workforce transformation! In this series, we've got incredible guests from Okta, Tubi, Edelman, Greenhouse, Findem, and more, sharing how top organizations are rethinking hiring, culture, and talent acquisition in today's fast-changing world. Greenhouse combines a structured, data-driven hiring approach with AI-embedded workflows that empower recruiters to focus on strategic, high-impact work. From sourcing top talent to personalizing the candidate experience, Greenhouse streamlines and optimizes the entire hiring process. This ensures that every hire is the right hire—eliminating bias, creating fairness, and helping teams make smarter, faster decisions. Over 7,500 companies, including HubSpot, Duolingo, and J.D. Power, trust Greenhouse to build better teams and turn talent into a strategic advantage. Want to learn how today's top companies are winning the talent game? Tune in now and visit Greenhouse.com to transform the way you hire. Thanks for listening. Please follow us on Instagram @NHPTalent and X @AdamJPosner. Visit www.thePOZcast.com for all episodes